Back to results
US 2022/0024907 A1Published application
Compositions and methods for inhibition of the jak pathway
AssigneeRigel Pharmaceuticals, Inc.
InventorsHui Li, Thilo J. Heckrodt, Yan Chen, Darren John McMurtrie, Vanessa Taylor, Rajinder Singh, Pingyu Ding, Rose Yen
Life of this patent
Estimating the term…
Abstract
Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful. Also disclosed are methods of making the compounds.
Claims16
A pharmaceutical composition, comprising:
- a means for inhibiting a Janus kinase (JAK);
- and
- a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.